LSE:GSK
LSE:GSKPharmaceuticals

GSK (LSE:GSK) Seeks European Expansion Of RSV Vaccine To Adults 18 And Older

Recently, GSK (LSE:GSK) announced that the European Medicines Agency accepted its regulatory application to expand the use of its RSV vaccine, Arexvy, to adults aged 18 and older. This announcement likely supported the company's 14% share price increase last month, alongside positive movements such as the FDA's review of linerixibat and early success in Tebipenem HBr trials. These advancements contrast the broader market, which experienced turbulence amid geopolitical tensions and surging oil...
AIM:FTC
AIM:FTCCommunications

UK Penny Stocks To Watch In June 2025

The UK market has recently faced challenges, with the FTSE 100 and FTSE 250 indices closing lower due to weak trade data from China, highlighting global economic concerns. Despite these broader market pressures, penny stocks continue to attract attention as they often represent smaller or newer companies that can offer significant value. While the term "penny stock" may seem outdated, it remains a relevant area for investors seeking growth opportunities at lower price points by focusing on...